Cancer survival in Africa, Asia, the Caribbean and Central America (SurvCan)

You are here: Home / Statistics / Comparative statistics by registry

Comparative statistics by cancer registry

Table1: Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site

(Lampang, Thailand, 1990-2000 cases followed-up until 2003)

Click on cancer site (ICD-10 code) for comparison

			%		No. of excluded cases					Included cases
Site	ICD-10	Total registered	HV	DCO	DCO	No. follow-up	Others	Total	%	No.	%
C00	Lip	33	97.0	0.0	0	0	0	0	0.0	33	100.0
C01-02	Tongue	76	93.4	0.0	0	0	0	0	0.0	76	100.0
C03-06	Oral cavity	124	83.9	4.8	6	0	0	6	4.8	118	95.2
C07-08	Salivary gland	33	75.8	3.0	1	0	0	1	3.0	32	97.0
C09	Tonsil	47	91.5	0.0	0	0	0	0	0.0	47	100.0
C11	Nasopharynx	169	85.2	0.0	0	0	0	0	0.0	169	100.0
C12-13	Hypopharynx	43	95.3	0.0	0	0	0	0	0.0	43	100.0
C15	Oesophagus	118	61.0	4.2	5	0	0	5	4.2	113	95.8
C16	Stomach	424	70.0	6.4	27	1	0	28	6.6	396	93.4
C18	Colon	522	59.0	18.4	96	0	1	97	18.6	425	81.4
C19-20	Rectum	250	83.6	0.4	1	0	0	1	0.4	249	99.6
C22	Liver	1707	29.7	14.7	251	1	0	252	14.8	1455	85.2
C23-24	Gall bladder	277	58.8	3.6	10	1	0	11	4.0	266	96.0
C25	Pancreas	162	45.7	2.5	4	0	0	4	2.5	158	97.5
C26	Gastrointestinal tract unspecified	151	51.7	7.3	11	0	0	11	7.3	140	92.7
C30-31	Nose/Sinuses	42	85.7	0.0	0	0	0	0	0.0	42	100.0
C32	Larynx	168	86.3	2.4	4	2	0	6	3.6	162	96.4
C33-34	Lung	3278	65.9	7.8	257	6	1	264	8.1	3014	91.9
C40-41	Bone	39	56.4	33.3	13	0	0	13	33.3	26	66.7
C43	Melanoma skin	50	100.0	0.0	0	0	0	0	0.0	50	100.0
C44	Other skin	296	95.9	1.4	4	0	0	4	1.4	292	98.6
C47+C49	Connective tissue	71	94.4	0.0	0	1	0	1	1.4	70	98.6
C50	Breast	842	89.9	1.4	12	0	0	12	1.4	830	98.6
C51	Vulva	30	96.7	0.0	0	0	0	0	0.0	30	100.0
C53	Cervix	1088	92.2	0.8	9	0	0	9	0.8	1079	99.2
C54	Corpus uteri	112	77.7	9.8	11	0	0	11	9.8	101	90.2
C56	Ovary	193	80.3	0.0	0	0	0	0	0.0	193	100.0
C60	Penis	71	88.7	1.4	1	0	0	1	1.4	70	98.6
C61	Prostate	176	88.1	2.8	5	0	0	5	2.8	171	97.2
C62	Testis	31	74.2	0.0	0	0	0	0	0.0	31	100.0
C64	Kidney	53	47.2	13.2	7	0	0	7	13.2	46	86.8
C65	Renal pelvis	39	97.4	0.0	0	0	0	0	0.0	39	100.0
C67	Urinary bladder	269	84.4	0.7	2	2	0	4	1.5	265	98.5
C70-72	Brain & nervous system	84	65.5	13.1	11	0	0	11	13.1	73	86.9
C73	Thyroid	140	76.4	5.0	7	0	0	7	5.0	133	95.0
C81	Hodgkin lymphoma	55	100.0	0.0	0	0	1	1	1.8	54	98.2
C82-85+C96	Non-Hodgkin lymphoma	368	100.0	0.0	0	0	0	0	0.0	368	100.0
C91	Lymphoid leukaemia	109	100.0	0.0	0	0	0	0	0.0	109	100.0
C92-94	Myeloid leukaemia	137	100.0	0.0	0	0	0	0	0.0	137	100.0
C95	Leukaemia unspecified	90	100.0	0.0	0	0	0	0	0.0	90	100.0

Other tables available for this registry:

- Table1:	Data quality indices - Proportion (%) of histologically verified and death certificate only cases, number and proportion of included and excluded cases by site (Lampang, Thailand, 1990-2000 cases followed-up until 2003)
- Table2a:	Number and proportion of cases with complete/incomplete follow-up and median follow-up (in months) by site (Lampang, Thailand, 1990-2000 cases followed-up until 2003)
- Table3:	Comparison of 1-, 3- and 5-year absolute and relative survival and 5-year age-standardized relative survival (ASRS) by site (Lampang, Thailand, 1990-2000 cases followed-up until 2003)
- Table4:	Site-wise number of cases, 5-year absolute and relative survival by sex and relative survival by age group (Lampang, Thailand, 1990-2000 cases followed-up until 2003)
- Table5b:	Proportion (%) of cases and 5-year absolute survival by extent of disease and site (Lampang, Thailand, 1990-2000)

Registry chapter:

Consult the chapter in Cancer survival in developping countries (Volume II)